Funding

Biorce

Spain · Healthtech · AI · Biotech

Develops AI infrastructure to improve clinical trial design and execution

Visit biorce.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$52MAlbert Nieto — Role not disclosedArthur Mensch — Role not disclosedDST Global Partners — Role not disclosedMustard Seed Maze — Role not disclosedNik Storonsky — Role not disclosedNorrsken VC — Role not disclosedPaulo Rosado — Role not disclosedYZR Capital — Role not disclosed

Investors

Albert NietoSeries AArthur MenschSeries ADST Global PartnersSeries AMustard Seed MazeSeries ANik StoronskySeries ANorrsken VCSeries APaulo RosadoSeries AYZR CapitalSeries A

Coverage

Feb 2, 2026Biorce · Series A

Similar companies

Estuary BiotherapeuticsEstuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.$93M · Series A
Abby CareAbby Care trains and supports eligible family members as paid caregivers, combining nurse-led care management with software that documents care at home.$82M · Series C
GasLabGasLab is developing a generative music platform that links AI-created tracks to participating artists and rights holders so they can share in the revenue.~$1M · Pre-seed
Sourcesbiorce.com ↗